Transcat (NASDAQ:TRNS) Stock: Insider Jaime Irick Buys 2,275 Shares

Transcat, Inc. (NASDAQ:TRNS) CEO Jaime Irick bought 2,275 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The stock was purchased at an average price of $101.26 per share, for a total transaction of $230,366.50. Following the completion of the acquisition, the chief executive officer owned 2,275 shares in the company, valued at $230,366.50. This represents a ? increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Transcat Stock Performance

Shares of NASDAQ:TRNS traded up $1.13 during midday trading on Friday, reaching $101.51. The company had a trading volume of 169,038 shares, compared to its average volume of 148,901. The company has a current ratio of 2.57, a quick ratio of 2.11 and a debt-to-equity ratio of 0.38. The stock has a market cap of $954.19 million, a P/E ratio of 211.48 and a beta of 0.61. The company’s 50 day moving average price is $86.71 and its 200 day moving average price is $82.24. Transcat, Inc. has a 52-week low of $50.23 and a 52-week high of $110.47.

Transcat (NASDAQ:TRNS) last issued its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.45 by $0.19. Transcat had a return on equity of 6.14% and a net margin of 1.26%. The business had revenue of $97.09 million during the quarter, compared to the consensus estimate of $92.46 million. As a group, sell-side analysts anticipate that Transcat, Inc. will post 1.84 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Russell Investments Group Ltd. raised its holdings in shares of Transcat by 41.8% during the third quarter. Russell Investments Group Ltd. now owns 24,929 shares of the scientific and technical instruments company’s stock worth $2,204,000 after purchasing an additional 7,348 shares during the last quarter. R Squared Ltd purchased a new position in Transcat during the third quarter valued at $274,000. Riverbridge Partners LLC raised its position in shares of Transcat by 8.4% during the 3rd quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock worth $19,404,000 after purchasing an additional 17,063 shares during the last quarter. Summit Creek Advisors LLC lifted its position in shares of Transcat by 23.8% in the third quarter. Summit Creek Advisors LLC now owns 58,135 shares of the scientific and technical instruments company’s stock valued at $5,140,000 after acquiring an additional 11,165 shares in the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Transcat during the 3rd quarter worth $221,000. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Northland Securities upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 price objective for the company in a research note on Wednesday, October 21st. Oppenheimer upgraded shares of Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 target price for the company in a research report on Wednesday. Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a research note on Tuesday, August 25th. Finally, CJS Securities assumed coverage on Transcat in a research note on Tuesday, October 27th. They issued an “outperform” rating and a $115.00 price objective for the company. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $108.33.

Transcat News Roundup

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
• Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
• Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
• Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
• Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target

About Transcat

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.